Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.21 USD | +0.61% | -9.52% | -13.84% |
01/05 | HSBC Adjusts Price Target on Bristol-Myers Squibb to $45 From $50 | MT |
01/05 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.84% | 89.62B | |
+33.25% | 699B | |
+28.59% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.81% | 236B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- UBS Adjusts Bristol-Myers Squibb Company Price Target to $75 From $73, Maintains Neutral Rating